December 3, 2020

Volume X, Number 338

Advertisement

December 03, 2020

Subscribe to Latest Legal News and Analysis

December 02, 2020

Subscribe to Latest Legal News and Analysis

December 01, 2020

Subscribe to Latest Legal News and Analysis

November 30, 2020

Subscribe to Latest Legal News and Analysis

Sparks Fly in DePuy Pinnacle 3rd Bellwether Trial

The third DePuy Pinnacle bellwether trial got off to a roaring start this week as Hon. Ed Kinkeade, District Judge for the United States District Court, Northern District of Texas, took control of his courtroom to set the tone for the trial. According to reports, he flatly denied both a continuance and a motion for a mistrial delivered by defendant, Johnson & Johnson, in the first few minutes of the proceedings. After lunch, Judge Kinkeade penalized both sides for wasting time over a witness objection. Later, Judge Kinkeade called a break with a warning to Johnson & Johnson’s lawyer that if he did not stand while objecting, he would be chastised in front of the jury.

Johnson & Johnson’s attempts to delay the trial are not surprising, considering their multiple failed attempts to stop the bellwether trials altogether. In addition to the seven plaintiffs involved in this trial, there are approximately eight thousand additional plaintiffs waiting for their day in court, or a portion of any global settlement.

This third bellwether case is being tried under the laws of California, which may deliver a different outcome than prior cases in terms of monetary damages. In one of those cases, Texas was forced by its punitive damages caps to decrease a nearly $500 million jury award to $150 million—California has no such limitations. Accordingly, it will be interesting to see not only the outcome of this bellwether case, but also how the case will progress given its fiery start.

Information on the MDL case:  In re: DePuy Orthopaedics Inc. Pinnacle Hip Implant Products Liability Litigation.

COPYRIGHT © 2020, STARK & STARKNational Law Review, Volume VI, Number 280
Advertisement

TRENDING LEGAL ANALYSIS

Advertisement
Advertisement

About this Author

Stefanie Colella Walsh, Pharmaceutical Litigation Attorney, Stark Law Firm
Shareholder

Stefanie Colella-Walsh is a Shareholder and member of Stark & Stark’s Litigation, Insurance Coverage & Liability, Intellectual Property and Mass Torts Groups where she concentrates her practice in complex litigation with a focus in mass tort and pharmaceutical litigation. She also handles litigation related to nursing home negligence and abuse claims, elder abuse, and assisted living facility litigation.

Recently, Ms. Colella-Walsh was a member of the national trial team involved the first trial in the country of a TVT-Secur transvaginal...

609-219-7416
Advertisement
Advertisement